1. Home
  2. FN vs NBIX Comparison

FN vs NBIX Comparison

Compare FN & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FN
  • NBIX
  • Stock Information
  • Founded
  • FN 1999
  • NBIX 1992
  • Country
  • FN Cayman Islands
  • NBIX United States
  • Employees
  • FN N/A
  • NBIX N/A
  • Industry
  • FN Telecommunications Equipment
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FN Utilities
  • NBIX Health Care
  • Exchange
  • FN Nasdaq
  • NBIX Nasdaq
  • Market Cap
  • FN 12.1B
  • NBIX 13.2B
  • IPO Year
  • FN 2010
  • NBIX 1996
  • Fundamental
  • Price
  • FN $369.99
  • NBIX $144.10
  • Analyst Decision
  • FN Buy
  • NBIX Strong Buy
  • Analyst Count
  • FN 7
  • NBIX 18
  • Target Price
  • FN $306.33
  • NBIX $161.50
  • AVG Volume (30 Days)
  • FN 943.1K
  • NBIX 771.5K
  • Earning Date
  • FN 11-03-2025
  • NBIX 10-29-2025
  • Dividend Yield
  • FN N/A
  • NBIX N/A
  • EPS Growth
  • FN 13.21
  • NBIX 2.97
  • EPS
  • FN 9.17
  • NBIX 3.39
  • Revenue
  • FN $3,419,327,000.00
  • NBIX $2,509,900,000.00
  • Revenue This Year
  • FN $17.77
  • NBIX $20.66
  • Revenue Next Year
  • FN $19.44
  • NBIX $14.64
  • P/E Ratio
  • FN $40.26
  • NBIX $42.56
  • Revenue Growth
  • FN 18.60
  • NBIX 18.42
  • 52 Week Low
  • FN $148.55
  • NBIX $84.23
  • 52 Week High
  • FN $377.56
  • NBIX $154.61
  • Technical
  • Relative Strength Index (RSI)
  • FN 65.06
  • NBIX 66.82
  • Support Level
  • FN $313.00
  • NBIX $135.61
  • Resistance Level
  • FN $360.00
  • NBIX $142.91
  • Average True Range (ATR)
  • FN 15.87
  • NBIX 3.43
  • MACD
  • FN 4.57
  • NBIX 0.76
  • Stochastic Oscillator
  • FN 93.10
  • NBIX 87.82

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: